Hydromorphone hydrochloride injection USP (2018-01-31)

Starting date:
January 31, 2018
Posting date:
January 31, 2018
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-65922

Affected Products

Hydromorphone hydrochloride injection USP

Reason

Product sterility may be compromised in affected lot due to the possibility of cracked vials

Depth of distribution

Hospitals in Canada

Affected products

Hydromorphone hydrochloride injection USP

DIN, NPN, DIN-HIM
DIN 02382636
Dosage form

Solution

Strength

10mg/mL

Lot or serial number

67240DD

Companies
Recalling Firm
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA
Marketing Authorization Holder
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA